These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13021768)

  • 1. [Obesity as metabolic problem].
    GROSSE-BROCKHOFF F
    Helv Med Acta; 1952 Oct; 19(4-5):271-90. PubMed ID: 13021768
    [No Abstract]   [Full Text] [Related]  

  • 2. Obesity: a complex metabolic problem.
    MURPHY R
    J Am Med Womens Assoc; 1962 Apr; 17():328-31. PubMed ID: 14477436
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between leptin level, index of insulin resistance and the main indicators of carbohydrate and lipid metabolism in patients with varying degrees of obesity].
    Kryvenko VI; Fedorova OP; Hrinenko TIu; Kachan IS
    Wiad Lek; 2014; 67(2 Pt 2):341-3. PubMed ID: 25796865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable isotopes in obesity research.
    Dolnikowski GG; Marsh JB; Das SK; Welty FK
    Mass Spectrom Rev; 2005; 24(3):311-27. PubMed ID: 15389849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic syndrome - a new look at a known problem].
    Płaczkowska S; Pawlik-Sobecka L; Kokot I; Piwowar A
    Wiad Lek; 2017; 70(5):970-976. PubMed ID: 29203751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome.
    Cooke AA; Connaughton RM; Lyons CL; McMorrow AM; Roche HM
    Eur J Pharmacol; 2016 Aug; 785():207-214. PubMed ID: 27083551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic cross talk between metabolic organs in obesity and metabolic diseases.
    Kim JB
    Exp Mol Med; 2016 Mar; 48(3):e214. PubMed ID: 26964830
    [No Abstract]   [Full Text] [Related]  

  • 8. Some metabolic characteristics of essential obesity.
    Schlechter P; Vill AM; Brambilla F
    Am J Clin Nutr; 1962 May; 10():433-42. PubMed ID: 14498513
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases.
    Kadomatsu T; Tabata M; Oike Y
    FEBS J; 2011 Feb; 278(4):559-64. PubMed ID: 21182596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the problem of steroid regulation of fat metabolism in persons with obesity].
    Kandrach M; Ermolenko R; Shonka I; Gregorova I
    Probl Endokrinol Gormonoter; 1965; 11(3):16-21. PubMed ID: 5865971
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of metabolic phenotyping in understanding obesity and related conditions in Gulf Co-operation Council countries.
    Ahmad MS; Ashrafian H; Alsaleh M; Holmes E
    Clin Obes; 2015 Dec; 5(6):302-11. PubMed ID: 26567983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.
    Rahtu-Korpela L; Karsikas S; Hörkkö S; Blanco Sequeiros R; Lammentausta E; Mäkelä KA; Herzig KH; Walkinshaw G; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Diabetes; 2014 Oct; 63(10):3324-33. PubMed ID: 24789921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity: is obesity metabolic?
    Jung RT; James WP
    Br J Hosp Med; 1980 Dec; 24(6):503-9. PubMed ID: 7272536
    [No Abstract]   [Full Text] [Related]  

  • 15. The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.
    Mazier W; Saucisse N; Gatta-Cherifi B; Cota D
    Trends Endocrinol Metab; 2015 Oct; 26(10):524-537. PubMed ID: 26412154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic demands as a factor in weight control.
    POLLACK H; CONSOLAZIO CF; ISAAC GJ
    J Am Med Assoc; 1958 May; 167(2):216-9. PubMed ID: 13538697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basal metabolism in obesity; study of basal metabolic rate in 615 obese patients].
    DE MELLO AV
    Hospital (Rio J); 1958 Jan; 53(1):77-9. PubMed ID: 13524824
    [No Abstract]   [Full Text] [Related]  

  • 18. The brain-gut axis in regulation of appetite and obesity.
    Dham S; Banerji MA
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():544-54. PubMed ID: 17237741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?
    Nduhirabandi F; du Toit EF; Lochner A
    Acta Physiol (Oxf); 2012 Jun; 205(2):209-23. PubMed ID: 22226301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients.
    Su X; Kong Y; Peng DQ
    Lipids Health Dis; 2018 Jul; 17(1):174. PubMed ID: 30053818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.